The functional group of RNA binding proteins included ELAVL1, ZRANB2 and HNRNPA1, whose role in alternative splicing of transcripts to serve tumour development have made them a focus of recent efforts to target altered RNA splicing in cancer [38, 39]. The gene discussed is ELAVL1; the disease is neoplasm.